低分子肝素治疗不稳定型心绞痛的临床疗效  

作　　者：郭建浩 陈若峰 周立尧 李剑平 

机构地区：[1]广东佛山市顺德区北滘医院心内科,528311

出　　处：《中国社区医师（医学专业）》2012年第35期98-99,共2页

摘　　要：目的:观察低分子肝素(速避凝)治疗不稳定型心绞痛(UAP)的有效性和安全性,以供临床借鉴和参考。方法:收治UAP患者65例,进行随机分组,均给予常规综合治疗,观察组在此基础上给予腹壁皮下注射速避凝。观察两组临床疗效和不良反应的差异。结果:与对照组相比较,观察组心绞痛和心电图改善程度明显较好,有显著的统计学差异(P<0.05)。两组在治疗期间发生的不良反应比较,无显著的统计学差异(P>0.05)。结论:采用速避凝治疗UAP可有效控制心绞痛发作,对患者的康复和预后具有积极的促进作用。Objective：Observe the effect of Fraxiparine in treatment of UAP efficacy and safety,for clinical reference and reference.Methods：Choose 65 patients with UAP from Jun.2012 to May.2010 in our hospital as the research object,were randomly divided into 2 groups,were given conventional treatment,observation group given abdominal subcutaneous injection of fraxiparine.Observe clinical efficacy and adverse reaction of the 2 group.Results：Compared with control group,observation group of angina and ECG significantly better,with significant statistical difference（P0.05）.Adverse reactions of the two group has no significant statistical difference（P0.05）.Conclusion：Fraxiparine in the treatment of UAP can effectively control the attack of angina pecto ris,rehabilitation and prognosis of patients with positive stimulative effect.

关 键 词：低分子肝素 不稳定型心绞痛 有效性 安全性 

分 类 号：R541.4[医药卫生—心血管疾病]